Open Access
Triazavirin—A Novel Effective Antiviral Drug
Alexey I. Nemytov
1, 2
,
Vladimir L. Rusinov
1, 2
,
Mikhail V Varaksin
1, 2
,
Evgeny N Ulomskiy
1, 2
,
Ilya I Butorin
1
,
Weijie Du
3
,
Zhiyong Sun
3
,
Valery Charushin
1, 2
Тип публикации: Journal Article
Дата публикации: 2022-11-22
scimago Q1
wos Q1
БС1
SJR: 1.273
CiteScore: 9.0
Impact factor: 4.9
ISSN: 16616596, 14220067
PubMed ID:
36498864
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Краткое описание
This review outlines the data of numerous studies relating to the broad-spectrum antiviral drug Triazavirin that was launched on the Russian pharmaceutical market in 2014 as an anti-influenza drug (the international non-patented name is Riamilovir). The range of antiviral activity of Triazavirin has been significantly expanded during recent years; in particular, it has been shown that Triazavirin exhibits activity against tick-borne encephalitis, Rift Valley fever, West Nile fever, and other infections of viral etiology. This drug has been approved for treatment of influenza and acute respiratory infections by the Russian Ministry of Health on the basis of comprehensive clinical trials involving over 450 patients. Triazavirin was found to be a highly effective and well-tolerated drug, allowing its over-the-counter sale. The recently published data on the use of Triazavirin in clinical practice for the treatment of patients with COVID-19 are discussed, with special attention paid to potential biological targets for this drug.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
3
4
|
|
|
Russian Chemical Bulletin
4 публикации, 12.9%
|
|
|
Chimica Techno Acta
3 публикации, 9.68%
|
|
|
Organic and Biomolecular Chemistry
2 публикации, 6.45%
|
|
|
Russian Chemical Reviews
2 публикации, 6.45%
|
|
|
Chemistry
1 публикация, 3.23%
|
|
|
Journal of Analytical Chemistry
1 публикация, 3.23%
|
|
|
Electrochimica Acta
1 публикация, 3.23%
|
|
|
Reviews in Medical Virology
1 публикация, 3.23%
|
|
|
Russian Journal of Immunology
1 публикация, 3.23%
|
|
|
Applied Organometallic Chemistry
1 публикация, 3.23%
|
|
|
Журнал аналитической химии
1 публикация, 3.23%
|
|
|
Mendeleev Communications
1 публикация, 3.23%
|
|
|
Journal of Heterocyclic Chemistry
1 публикация, 3.23%
|
|
|
Future Science OA
1 публикация, 3.23%
|
|
|
Russian Journal of Organic Chemistry
1 публикация, 3.23%
|
|
|
ChemPlusChem
1 публикация, 3.23%
|
|
|
Journal of Molecular Structure
1 публикация, 3.23%
|
|
|
Журнал органической химии
1 публикация, 3.23%
|
|
|
Synthesis
1 публикация, 3.23%
|
|
|
ChemistrySelect
1 публикация, 3.23%
|
|
|
International Journal of Antimicrobial Agents
1 публикация, 3.23%
|
|
|
Meditsinskiy sovet = Medical Council
1 публикация, 3.23%
|
|
|
Infection
1 публикация, 3.23%
|
|
|
RSC Advances
1 публикация, 3.23%
|
|
|
1
2
3
4
|
Издатели
|
1
2
3
4
5
|
|
|
Springer Nature
5 публикаций, 16.13%
|
|
|
Wiley
5 публикаций, 16.13%
|
|
|
Royal Society of Chemistry (RSC)
3 публикации, 9.68%
|
|
|
Pleiades Publishing
3 публикации, 9.68%
|
|
|
Elsevier
3 публикации, 9.68%
|
|
|
Ural Federal University
3 публикации, 9.68%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
2 публикации, 6.45%
|
|
|
MDPI
1 публикация, 3.23%
|
|
|
Russian Society of Immunology
1 публикация, 3.23%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 3.23%
|
|
|
Taylor & Francis
1 публикация, 3.23%
|
|
|
The Russian Academy of Sciences
1 публикация, 3.23%
|
|
|
Georg Thieme Verlag KG
1 публикация, 3.23%
|
|
|
Remedium, Ltd.
1 публикация, 3.23%
|
|
|
1
2
3
4
5
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
31
Всего цитирований:
31
Цитирований c 2024:
24
(77.42%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Nemytov A. I. et al. Triazavirin—A Novel Effective Antiviral Drug // International Journal of Molecular Sciences. 2022. Vol. 23. No. 23. p. 14537.
ГОСТ со всеми авторами (до 50)
Скопировать
Nemytov A. I., Rusinov V. L., Varaksin M. V., Ulomskiy E. N., Savateev K. V., Butorin I. I., Du W., Sun Z., Charushin V. Triazavirin—A Novel Effective Antiviral Drug // International Journal of Molecular Sciences. 2022. Vol. 23. No. 23. p. 14537.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3390/ijms232314537
UR - https://doi.org/10.3390/ijms232314537
TI - Triazavirin—A Novel Effective Antiviral Drug
T2 - International Journal of Molecular Sciences
AU - Nemytov, Alexey I.
AU - Rusinov, Vladimir L.
AU - Varaksin, Mikhail V
AU - Ulomskiy, Evgeny N
AU - Savateev, Konstantin V
AU - Butorin, Ilya I
AU - Du, Weijie
AU - Sun, Zhiyong
AU - Charushin, Valery
PY - 2022
DA - 2022/11/22
PB - MDPI
SP - 14537
IS - 23
VL - 23
PMID - 36498864
SN - 1661-6596
SN - 1422-0067
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2022_Nemytov,
author = {Alexey I. Nemytov and Vladimir L. Rusinov and Mikhail V Varaksin and Evgeny N Ulomskiy and Konstantin V Savateev and Ilya I Butorin and Weijie Du and Zhiyong Sun and Valery Charushin},
title = {Triazavirin—A Novel Effective Antiviral Drug},
journal = {International Journal of Molecular Sciences},
year = {2022},
volume = {23},
publisher = {MDPI},
month = {nov},
url = {https://doi.org/10.3390/ijms232314537},
number = {23},
pages = {14537},
doi = {10.3390/ijms232314537}
}
Цитировать
MLA
Скопировать
Nemytov, Alexey I., et al. “Triazavirin—A Novel Effective Antiviral Drug.” International Journal of Molecular Sciences, vol. 23, no. 23, Nov. 2022, p. 14537. https://doi.org/10.3390/ijms232314537.